Author

Achim Rau

Institution: University of Tübingen

Observed institutions: Universitätsklinikum Tübingen, Institut für Neuropathologie, University of Tübingen

ORCID: 0000-0003-2497-7038

Observed ORCID: 0000-0003-2497-7038

OpenAlex ID: A5020108409

CD147 a direct target of miR-146a supports energy metabolism and promotes tumor growth in ALK+ ALCL

2022 · Ivonne-Aidee Montes-Mojarro, Julia Steinhilber, et al. · Leukemia · 14

FACILITATE: A real-world, multicenter, prospective study investigating the utility of a rapid, fully automated real-time PCR assay versus local reference methods for detecting epidermal growth factor receptor variants in NSCLC

2023 · Anke Behnke, Anne Cayre, et al. · Pathology & Oncology Research · 11

Altered Spatial Composition of the Immune Cell Repertoire in Association to CD34+ Blasts in Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia

2021 · Marcus Bauer, Christoforos Vaxevanis, et al. · Cancers · 11

Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies

2021 · Magdalena M. Brune, Achim Rau, et al. · Cancers · 7

Targeted NGS on sequential bone marrow biopsies aids in the evaluation of cytopenias and monocytosis and documents clonal evolution—a proof of principle study

2023 · Dominik Nann, Achim Rau, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2

Assessment of genomic instability and homologous recombination repair in ovarian cancer using the Oncomine Comprehensive Assay Plus

2026 · Isabell Goetting, Achim Rau, et al. · Oncotarget

Works count: 6

Citation count: 45

H-index: 4

I10-index: 3